Latest Dendreon Corp (DNDN) Headlines Biotech E
Post# of 67
Posted On: 03/12/2014 8:18:20 PM
Latest Dendreon Corp (DNDN) Headlines
Biotech Earnings Checkup: CLDX, DNDN, OPX
George Budwell, The Motley Fool - Motley Fool - Thu Mar 06, 5:30PM CST
Earnings are the lifeblood of a company. They speak to a company's past, present, and most importantly for investors, future. And they give an important window into the overall health of a company. So, with that in mind, let's dig into the earnings...
'Fast Money' Recap: China Syndrome
at The Street - Thu Mar 06, 4:00AM CST
The trading panel discussed how to invest in and around China.
Today's Dead Cat Bounce Stock Is Dendreon (DNDN)
at The Street - Wed Mar 05, 1:01PM CST
Trade-Ideas LLC identified Dendreon (DNDN) as a "dead cat bounce" (down big yesterday but up big today) candidate
Price Movements, Clinical Trial Results, and Solid Financial Reports - Analyst Notes on Pfizer, Dendreon, DepoMed, Globus Medical, and Array
PR Newswire - Wed Mar 05, 12:13PM CST
Today, Analysts Review released its analysts' notes regarding Pfizer Inc. (NYSE: PFE), Dendreon Corp. (NASDAQ: DNDN), DepoMed Inc. (NASDAQ: DEPO), Globus Medical, Inc. (NYSE: GMED), and Array BioPharma, Inc. (NASDAQ: ARRY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Mar 05, 9:58AM CST
Last week saw companies like Medivation, Arena and VIVUS reporting fourth quarter results. But, the spotlight remained on InterMune with its late-stage data on Esbriet.
Dendreon Corp.: The Biggest Loser in Biotech Today
David Williamson, The Motley Fool - Motley Fool - Tue Mar 04, 6:57PM CST
After popping 15% yesterday after the company released earnings, shares of Dendreon Corp . slipped back 7% today, showing that investors may have sobered up after taking time to digest the earnings news. The company did sell more of its drug...
Is Medivation Inc's Recent Pullback an Entry Opportunity?
Cory Renauer, The Motley Fool - Motley Fool - Tue Mar 04, 5:30PM CST
Medivation reported fourth quarter 2013 earnings after the bell on February 27 that beat estimates on both the top and bottom lines. Fourth quarter revenue grew 163% on year to $96.61 million, beating estimates by almost $24 million. While the...
Narrower-than-Expected Loss at Dendreon Drives Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 9:40AM CST
Dendreon reported 4Q13 loss of 23 cents per share, narrower than the Zacks Consensus Estimate of a loss of 37 cents per share
Critical Alerts For Dendreon, Qualcomm, Urban Outfitters, LinkedIn, and Proto Labs Released By InvestorsObserver
PR Newswire - Tue Mar 04, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for DNDN, QCOM, URBN, LNKD, and PRLB.
Today's Biggest Biotech Stories: Dendreon, AbbVie, and Omeros
Leo Sun, The Motley Fool - Motley Fool - Tue Mar 04, 8:06AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a closer look at three health care stocks -- ...
Dendreon Corp. (DNDN) Soars: Stock Rises 14.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 7:51AM CST
Dendreon Corp. was a big mover last session, as its shares rose nearly 15% on the day.
'Fast Money' Recap: Ukraine Concerns
at The Street - Tue Mar 04, 4:00AM CST
The trading panel discussed how the crisis is affecting foreign markets and gold.
Investors Are in Love With Dendreon Corporation
Brian Orelli, The Motley Fool - Motley Fool - Mon Mar 03, 6:58PM CST
Dendreon ended up 15% today. I have no idea why. There didn't seem to be anything in today's press releases nor on the conference call that justified that kind of move. Let's take a few quotes that John Johnson, Dendreon's chairman, president,...
Most active Nasdaq-traded stocks
AP - Mon Mar 03, 5:04PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
Why Plug Power, Dendreon, and Pacific Ethanol Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 03, 4:15PM CST
The broad-based S&P 500 finally had a day of positive economic data that it could rely on to push higher, but it wound up being thwarted by negative geopolitical issues that pressured markets from the opening bell. Perhaps no story is of...
Ford and Yandex are big market movers
AP - Mon Mar 03, 3:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
Why Dendreon Corporation Shares Soared
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 03, 11:15AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Dendreon , a biopharmaceutical company...
Why Dendreon Corporation (DNDN) Is Soaring Today
at The Street - Mon Mar 03, 9:27AM CST
Dendreon Corporation (DNDN) soars after the biotechnology company reported fourth-quarter earnings that surpassed analysts' expectations. Dendreon reported a loss of 17 cents per share, which beat the Capital IQ consensus estimate of a loss of 24...
Dendreon Announces Plans to Make PROVENGE(R) Commercially Available in Europe
Business Wire - Mon Mar 03, 6:31AM CST
Dendreon Corporation today announced that it plans to make PROVENGE(R) (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) available in Europe, beginning with Germany and the United Kingdom.
Biotech Earnings Checkup: CLDX, DNDN, OPX
George Budwell, The Motley Fool - Motley Fool - Thu Mar 06, 5:30PM CST
Earnings are the lifeblood of a company. They speak to a company's past, present, and most importantly for investors, future. And they give an important window into the overall health of a company. So, with that in mind, let's dig into the earnings...
'Fast Money' Recap: China Syndrome
at The Street - Thu Mar 06, 4:00AM CST
The trading panel discussed how to invest in and around China.
Today's Dead Cat Bounce Stock Is Dendreon (DNDN)
at The Street - Wed Mar 05, 1:01PM CST
Trade-Ideas LLC identified Dendreon (DNDN) as a "dead cat bounce" (down big yesterday but up big today) candidate
Price Movements, Clinical Trial Results, and Solid Financial Reports - Analyst Notes on Pfizer, Dendreon, DepoMed, Globus Medical, and Array
PR Newswire - Wed Mar 05, 12:13PM CST
Today, Analysts Review released its analysts' notes regarding Pfizer Inc. (NYSE: PFE), Dendreon Corp. (NASDAQ: DNDN), DepoMed Inc. (NASDAQ: DEPO), Globus Medical, Inc. (NYSE: GMED), and Array BioPharma, Inc. (NASDAQ: ARRY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Mar 05, 9:58AM CST
Last week saw companies like Medivation, Arena and VIVUS reporting fourth quarter results. But, the spotlight remained on InterMune with its late-stage data on Esbriet.
Dendreon Corp.: The Biggest Loser in Biotech Today
David Williamson, The Motley Fool - Motley Fool - Tue Mar 04, 6:57PM CST
After popping 15% yesterday after the company released earnings, shares of Dendreon Corp . slipped back 7% today, showing that investors may have sobered up after taking time to digest the earnings news. The company did sell more of its drug...
Is Medivation Inc's Recent Pullback an Entry Opportunity?
Cory Renauer, The Motley Fool - Motley Fool - Tue Mar 04, 5:30PM CST
Medivation reported fourth quarter 2013 earnings after the bell on February 27 that beat estimates on both the top and bottom lines. Fourth quarter revenue grew 163% on year to $96.61 million, beating estimates by almost $24 million. While the...
Narrower-than-Expected Loss at Dendreon Drives Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 9:40AM CST
Dendreon reported 4Q13 loss of 23 cents per share, narrower than the Zacks Consensus Estimate of a loss of 37 cents per share
Critical Alerts For Dendreon, Qualcomm, Urban Outfitters, LinkedIn, and Proto Labs Released By InvestorsObserver
PR Newswire - Tue Mar 04, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for DNDN, QCOM, URBN, LNKD, and PRLB.
Today's Biggest Biotech Stories: Dendreon, AbbVie, and Omeros
Leo Sun, The Motley Fool - Motley Fool - Tue Mar 04, 8:06AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a closer look at three health care stocks -- ...
Dendreon Corp. (DNDN) Soars: Stock Rises 14.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 7:51AM CST
Dendreon Corp. was a big mover last session, as its shares rose nearly 15% on the day.
'Fast Money' Recap: Ukraine Concerns
at The Street - Tue Mar 04, 4:00AM CST
The trading panel discussed how the crisis is affecting foreign markets and gold.
Investors Are in Love With Dendreon Corporation
Brian Orelli, The Motley Fool - Motley Fool - Mon Mar 03, 6:58PM CST
Dendreon ended up 15% today. I have no idea why. There didn't seem to be anything in today's press releases nor on the conference call that justified that kind of move. Let's take a few quotes that John Johnson, Dendreon's chairman, president,...
Most active Nasdaq-traded stocks
AP - Mon Mar 03, 5:04PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
Why Plug Power, Dendreon, and Pacific Ethanol Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 03, 4:15PM CST
The broad-based S&P 500 finally had a day of positive economic data that it could rely on to push higher, but it wound up being thwarted by negative geopolitical issues that pressured markets from the opening bell. Perhaps no story is of...
Ford and Yandex are big market movers
AP - Mon Mar 03, 3:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
Why Dendreon Corporation Shares Soared
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 03, 11:15AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Dendreon , a biopharmaceutical company...
Why Dendreon Corporation (DNDN) Is Soaring Today
at The Street - Mon Mar 03, 9:27AM CST
Dendreon Corporation (DNDN) soars after the biotechnology company reported fourth-quarter earnings that surpassed analysts' expectations. Dendreon reported a loss of 17 cents per share, which beat the Capital IQ consensus estimate of a loss of 24...
Dendreon Announces Plans to Make PROVENGE(R) Commercially Available in Europe
Business Wire - Mon Mar 03, 6:31AM CST
Dendreon Corporation today announced that it plans to make PROVENGE(R) (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) available in Europe, beginning with Germany and the United Kingdom.
(0)
(0)Dendreon Corp. (DNDNQ) Stock Research Links
Scroll down for more posts ▼